Psychological support of skin cancer patients

British Journal of Dermatology

Volumn 167, Issue SUPPL. 2, 2012, Pages 105-110

  Peters, E M J ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; ENVIRONMENTAL FACTOR; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION; IMMUNE RESPONSE; LIFESTYLE; MENTAL STRESS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SKIN CANCER; TUMOR GROWTH; ULTRAVIOLET RADIATION;

CHRONIC DISEASE; HUMANS; NEUROSECRETORY SYSTEMS; PSYCHONEUROIMMUNOLOGY; PSYCHOTHERAPY; SKIN NEOPLASMS; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 84864986879     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11094.x     Document Type: Review

References (56)

1. Fawzy FI, Cousins N, Fawzy NW, et al. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990; 47: 720-5.
2. Fawzy FI, Kemeny ME, Fawzy NW, et al. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 1990; 47: 729-35.
3. Boesen EH, Ross L, Frederiksen K, et al. Psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study. J Clin Oncol 2005; 23: 1270-7.
4. Holmes A, Wellman CL,. Stress-induced prefrontal reorganization and executive dysfunction in rodents. Neurosci Biobehav Rev 2009; 33: 773-83.
5. Schaepe KS,. Bad news and first impressions: patient and family caregiver accounts of learning the cancer diagnosis. Soc Sci Med 2011; 73: 912-21.
6. Tobin GA, Begley C,. Receiving bad news: a phenomenological exploration of the lived experience of receiving a cancer diagnosis. Cancer Nurs 2008; 31: E31-9.
7. Kaplan M,. SPIKES: a framework for breaking bad news to patients with cancer. Clin J Oncol Nurs 2010; 14: 514-16.
8. Book K, Marten-Mittag B, Henrich G, et al. Distress screening in oncology-evaluation of the Questionnaire on Distress in Cancer Patients-short form (QSC-R10) in a German sample. Psychooncology 2011; 20: 287-93.
9. Knight L, Mussell M, Brandl T, et al. Development and psychometric evaluation of the basic documentation for psycho-oncology, a tool for standardized assessment of cancer patients. J Psychosom Res 2008; 64: 373-81.
10. Herschbach P, Keller M, Knight L, et al. Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer 2004; 91: 504-11.
11. Tausk F, Elenkov I, Moynihan J,. Psychoneuroimmunology. Dermatol Ther 2008; 21: 22-31.
12. Ben-Eliyahu S, Page GG, Schleifer SJ,. Stress, NK cells, and cancer: still a promissory note. Brain Behav Immun 2007; 21: 881-7.
13. Godbout JP, Glaser R,. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol 2006; 1: 421-7.
14. Fleshner M, Laudenslager ML,. Psychoneuroimmunology: then and now. Behav Cogn Neurosci Rev 2004; 3: 114-30.
15. Dhabhar FS,. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. NeuroImmunoModulation 2009; 16: 300-17.
16. Li T, Harada M, Tamada K, et al. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4 + T cells. Anticancer Res 1997; 17: 4259-68.
17. Yang EV, Kim SJ, Donovan EL, et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 2009; 23: 267-75.
18. Palma C,. Tachykinins and their receptors in human malignancies. Curr Drug Targets 2006; 7: 1043-52.
19. Peters EM, Raap U, Welker P, et al. Neurotrophins act as neuroendocrine regulators of skin homeostasis in health and disease. Horm Metab Res 2007; 39: 110-24.
20. Castellani ML, Galzio RJ, Felaco P, et al. VEGF, substance P and stress, new aspects: a revisited study. J Biol Regul Homeost Agents 2010; 24: 229-37.
21. Pavlovic S, Daniltchenko M, Tobin DJ, et al. Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 2008; 128: 434-46.
22. Peters EM, Kuhlmei A, Tobin DJ, et al. Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun 2005; 19: 252-62.
23. Guidolin D, Crivellato E, Nico B, et al. An image analysis of the spatial distribution of perivascular mast cells in human melanoma. Int J Mol Med 2006; 17: 981-7.
24. Peters EM, Ericson ME, Hosoi J, et al. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol 2006; 126: 1937-47.
25. Pavlovic S, Liezmann C, Blois SM, et al. Substance P is a key mediator of stress-induced protection from allergic sensitization via modified antigen presentation. J Immunol 2011; 186: 848-55.
26. Shindo M, Yoshida Y,. Regulatory T cells and skin tumors. Recent Pat Inflamm Allergy Drug Discov 2010; 4: 249-54.
27. Reiche EM, Nunes SO, Morimoto HK,. Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5: 617-25.
28. Wang HT, Choi B, Tang MS,. Melanocytes are deficient in repair of oxidative DNA damage and UV-induced photoproducts. Proc Natl Acad Sci U S A 2010; 107: 12180-5.
29. Smit NP, van Nieuwpoort FA, Marrot L, et al. Increased melanogenesis is a risk factor for oxidative DNA damage-study on cultured melanocytes and atypical nevus cells. Photochem Photobiol 2008; 84: 550-5.
30. Moller P, Wallin H, Knudsen LE,. Oxidative stress associated with exercise, psychological stress and life-style factors. Chem Biol Interact 1996; 102: 17-36.
31. Irie M, Asami S, Nagata S, et al. Relationships between perceived workload, stress and oxidative DNA damage. Int Arch Occup Environ Health 2001; 74: 153-7.
32. Peters EM, Liezmann C, Spatz K, et al. Nerve growth factor partially recovers inflamed skin from stress-induced worsening in allergic inflammation. J Invest Dermatol 2011; 131: 735-43.
33. Sa-Rocha VM, Sa-Rocha LC, Palermo-Neto J,. Variations in behavior, innate immunity and host resistance to B16F10 melanoma growth in mice that present social stable hierarchical ranks. Physiol Behav 2006; 88: 108-15.
34. Azpiroz A, De Miguel Z, Fano E, et al. Relations between different coping strategies for social stress, tumor development and neuroendocrine and immune activity in male mice. Brain Behav Immun 2008; 22: 690-8.
35. Costa-Pinto FA, Cohn DW, Sa-Rocha VM, et al. Behavior: a relevant tool for brain-immune system interaction studies. Ann N Y Acad Sci 2009; 1153: 107-19.
36. Price MA, Tennant CC, Butow PN, et al. The role of psychosocial factors in the development of breast carcinoma: part II. Life event stressors, social support, defense style, and emotional control and their interactions. Cancer 2001; 91: 686-97.
37. Bigatti SM, Brown LF, Steiner JL, et al. Breast cancer in a wife: how husbands cope and how well it works. Cancer Nurs 2011; 34: 193-201.
38. Baltrusch HJ, Stangel W, Titze I,. Stress, cancer and immunity. New developments in biopsychosocial and psychoneuroimmunologic research. Acta Neurol (Napoli) 1991; 13: 315-27.
39. Garssen B,. Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev 2004; 24: 315-38.
40. Brown KW, Levy AR, Rosberger Z, et al. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med 2003; 65: 636-43.
41. Correll A, Tuettenberg A, Becker C, et al. Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination. Exp Dermatol 2010; 19: e213-21.
42. Saul AN, Oberyszyn TM, Daugherty C, et al. Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst 2005; 97: 1760-7.
43. Lehto US, Ojanen M, Kellokumpu-Lehtinen P,. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. Ann Oncol 2005; 16: 805-16.
44. Kissane D,. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 2009; 18: 1-5.
45. Al-Shakhli H, Harcourt D, Kenealy J,. Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic. J Plast Reconstr Aesthet Surg 2006; 59: 479-86.
46. Kelly B, Raphael B, Smithers M, et al. Psychological responses to malignant melanoma. An investigation of traumatic stress reactions to life-threatening illness. Gen Hosp Psychiatry 1995; 17: 126-34.
47. Winzer A, Hoppe A, Altenhoff J, et al. Interest in a psycho-educational group intervention among out-patients with malignant melanoma in relation to their need: which patients are likely to participate? Psychooncology 2009; 18: 1179-88.
48. Dahl AA,. Link between personality and cancer. Future Oncol 2010; 6: 691-707.
49. Cao L, Liu X, Lin EJ, et al. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell 2010; 142: 52-64.
50. Vos PJ, Visser AP, Garssen B, et al. Effects of delayed psychosocial interventions versus early psychosocial interventions for women with early stage breast cancer. Patient Educ Couns 2006; 60: 212-19.
51. Fawzy FI, Canada AL, Fawzy NW,. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry 2003; 60: 100-3.
52. Cornish D, Holterhues C, van de Poll-Franse LV, et al. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009; 20 (Suppl. 6): vi51-8.
53. Fawzy FI, Fawzy NW, Hyun CS, et al. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993; 50: 681-9.
54. Boesen E, Boesen S, Christensen S, et al. Comparison of participants and non-participants in a randomized psychosocial intervention study among patients with malignant melanoma. Psychosomatics 2007; 48: 510-16.
55. Boesen EH, Boesen SH, Frederiksen K, et al. Survival after a psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study. J Clin Oncol 2007; 25: 5698-703.
56. Dhabhar FS, Saul AN, Daugherty C, et al. Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma. Brain Behav Immun 2010; 24: 127-37.